Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.

@article{Yancheva2009GinkgoBE,
  title={Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.},
  author={Stiliana Yancheva and Ralf Ihl and Gloria Nikolova and Plamen A. Panayotov and S. Schl{\"a}fke and Robert Hoerr},
  journal={Aging & mental health},
  year={2009},
  volume={13 2},
  pages={
          183-90
        }
}
OBJECTIVE This randomised, double-blind exploratory trial was undertaken to compare treatment effects and tolerability of EGb 761(R), donepezil and combined treatment in patients with AD and neuropsychiatric features. METHOD We enrolled 96 outpatients, aged 50 years or above, who met the NINCDS/ADRDA criteria for probable AD, scored below 36 on the TE4D, a screening test for dementia, below 6 on the Clock-Drawing Test (CDT) and between 9 and 23 on the SKT, a cross-culturally validated… CONTINUE READING
BETA

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 42 CITATIONS

Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use

  • Drugs & therapy perspectives : for rational drug selection and use
  • 2018
VIEW 9 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Ginkgo biloba in Alzheimer’s disease: a systematic review

  • Wiener Medizinische Wochenschrift
  • 2010
VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Similar Papers

Loading similar papers…